Mental disorders in Parkinson's disease after treatment with L-DOPA.

Suppr

超能文献

作者信息

Rondot P, de Recondo J, Coignet A, Ziegler M

出版信息

Adv Neurol. 1984;40:259-69.

PMID:6695602

Abstract

摘要

相似文献

Mental disorders in Parkinson's disease after treatment with L-DOPA.

Adv Neurol. 1984;40:259-69.

[Mental disorders in patients with Parkinson's disease treated with L-dopa].

Clin Ter. 1981 Jun 15;97(5):473-9.

[Prevalence of mental disorders in persons with Parkinson's disease].

Ned Tijdschr Geneeskd. 1998 Jan 3;142(1):27-31.

Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease.

Adv Neurol. 1996;69:541-4.

[Secondary effects of prolonged levodopa therapy in Parkinson's disease].

Med Clin (Barc). 1985 Jun 15;85(3):88-91.

Neuropsychological findings in Parkinson's disease: a comparison between various tests during long-term levodopa therapy.

Int J Neurol. 1975;10(1-4):222-32.

[Reports on mental disorders in Parkinson disease in relation to treatment with L-dopa].

Riv Neurobiol. 1983 Oct-Dec;29(4):577-84.

[Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].

Rev Neurol (Paris). 2002 Feb;158(2):203-10.

Psychiatric complications of levodopa therapy of Parkinson's disease.

Adv Neurol. 1984;40:271-7.

[Psychiatric disorders in elderly patients with Parkinson's disease and their treatments].

Rev Med Suisse Romande. 2001 Feb;121(2):145-51.

引用本文的文献

Cerebellar GABA Levels and Cognitive Interference in Parkinson's disease and Healthy Comparators.

J Pers Med. 2020 Dec 28;11(1):16. doi: 10.3390/jpm11010016.

[Parkinson's disease and psychoses].

Neuropsychiatr. 2015;29(1):1-13. doi: 10.1007/s40211-014-0132-8. Epub 2015 Jan 14.

Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Drugs Aging. 2008;25(8):665-82. doi: 10.2165/00002512-200825080-00004.

Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease.

J Neural Transm (Vienna). 1996;103(4):421-32. doi: 10.1007/BF01276418.

Clozapine-induced agranulocytosis and thrombopenia in a patient with dopaminergic psychosis.

J Neural Transm (Vienna). 1997;104(11-12):1305-11. doi: 10.1007/BF01294731.

Hallucinosis in idiopathic Parkinson's disease.

J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):434-40. doi: 10.1136/jnnp.63.4.434.

Visual hallucinosis: the major clinical determinant of distorted chromatic contour perception in Parkinson's disease.

J Neural Transm (Vienna). 1996;103(10):1195-204. doi: 10.1007/BF01271204.

Differing patterns of psychiatric impairment in Alzheimer and demented parkinsonian patients.

Ital J Neurol Sci. 1994 Nov;15(8):407-11. doi: 10.1007/BF02339904.

Visual hallucinations in the elderly associated with the use of levodopa.

Postgrad Med J. 1989 Jun;65(764):358-61. doi: 10.1136/pgmj.65.764.358.

Parkinson's disease.

CMAJ. 1989 Mar 1;140(5):507-14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验